| Year |
Citation |
Score |
| 2024 |
Upadhyay R, Gogineni E, Tocaj G, Ma SJ, Bonomi M, Bhateja P, Konieczkowski DJ, Baliga S, Mitchell DL, Jhawar SR, Zhu S, Grecula JC, Dibs K, Gamez ME, Blakaj DM. Palliative Quad Shot Radiation Therapy with or without Concurrent Immune Checkpoint Inhibition for Head and Neck Cancer. Cancers. 16. PMID 38473406 DOI: 10.3390/cancers16051049 |
0.319 |
|
| 2023 |
Baliga S, Yildiz V, Barve R, Farag A, Bhateja P, Gogineni E, Mitchell D, Konieczkowski D, Grecula J, Ma SJ, Zhu S, Liu X, Bonomi M, Blakaj DM. Outcomes of definitive local therapy with intensity-modulated radiation therapy in elderly patients ≥70 years with HPV-associated oropharyngeal cancer. Journal of Medical Virology. 95: e29293. PMID 38054393 DOI: 10.1002/jmv.29293 |
0.304 |
|
| 2022 |
Gillison ML, Ferris RL, Harris J, Colevas AD, Mell LK, Kong C, Jordan RC, Moore KL, Truong MT, Kirsch C, Chakravarti A, Blakaj DM, Clump DA, Ohr JP, Deeken JF, et al. Safety of nivolumab added to chemoradiotherapy platforms for intermediate and high-risk local-regionally advanced head and neck squamous cell carcinoma: RTOG Foundation 3504. International Journal of Radiation Oncology, Biology, Physics. PMID 36228746 DOI: 10.1016/j.ijrobp.2022.10.008 |
0.3 |
|
| 2021 |
Karivedu V, Bonomi M, Issa M, Blakaj A, Klamer BG, Pan X, Old M, Bhateja P, Kang S, Seim N, Ozer E, Agrawal A, Mitchell D, Gamez ME, Grecula J, ... ... Blakaj D, et al. Treatment Outcomes of Head and Neck Cancer Patients in the Elderly Receiving Different Chemoradiation Combinations: A Single-Center Experience. Oncology Research and Treatment. 1-7. PMID 34515190 DOI: 10.1159/000518548 |
0.331 |
|
| 2021 |
Bauman JE, Harris J, Uppaluri R, Yao M, Ferris RL, Chen J, Jordan RC, Joshi NP, Jujjuvaparu S, Blakaj DM, Henson C, Sheqwara J, Mell LK, Sen N, Clump DA, et al. NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer. Cancers. 13. PMID 34207599 DOI: 10.3390/cancers13122882 |
0.337 |
|
| 2020 |
Perlow HK, Dibs K, Liu K, Jiang W, Rajappa P, Blakaj DM, Palmer J, Raval RR. Whole-Brain Radiation Therapy Versus Stereotactic Radiosurgery for Cerebral Metastases. Neurosurgery Clinics of North America. 31: 565-573. PMID 32921352 DOI: 10.1016/J.Nec.2020.06.006 |
0.354 |
|
| 2020 |
Baliga S, Klamer B, Jhawar S, Gamez M, Mitchell D, Blakaj A, Grecula J, Gardner U, Dibs K, Old M, Seim N, Kang S, Carrau R, Agrawal A, Karivedu V, ... ... Blakaj D, et al. Identification of Clinical and Socioeconomic Predictors of Adjuvant Therapy after Trans-Oral Robotic Surgery in Patients with Oropharyngeal Squamous Cell Carcinoma. Cancers. 12. PMID 32882857 DOI: 10.3390/Cancers12092474 |
0.435 |
|
| 2020 |
Palmer JD, Gamez ME, Ranta K, Ruiz-Garcia H, Peterson JL, Blakaj DM, Prevedello D, Carrau R, Mahajan A, Chaichana KL, Trifiletti DM. Radiation therapy strategies for skull-base malignancies. Journal of Neuro-Oncology. PMID 32785868 DOI: 10.1007/S11060-020-03569-7 |
0.351 |
|
| 2020 |
Wang SJ, Jhawar SR, Rivera-Nunez Z, Silk AW, Byun J, Miller E, Blakaj D, Parikh RR, Weiner J, Goyal S. The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients. Cureus. 12: e8767. PMID 32714704 DOI: 10.7759/Cureus.8767 |
0.372 |
|
| 2020 |
Bonomi M, Bhateja P, Issa M, Klamer B, Pan X, Blakaj A, Karivedu V, Mousa L, Mitchell D, Gamez M, Kang S, Siem N, Old M, Carrau R, Rocco J, ... Blakaj D, et al. A predictive survival model for patients with head and neck squamous cell carcinoma treated with immune check point inhibitors. Oral Oncology. 110: 104900. PMID 32702630 DOI: 10.1016/J.Oraloncology.2020.104900 |
0.382 |
|
| 2020 |
London NR, Mohyeldin A, Daoud G, Gamez ME, Blakaj D, Bonomi M, Prevedello DM, Carrau RL. Sinonasal undifferentiated carcinoma: Institutional trend toward induction chemotherapy followed by definitive chemoradiation. Head & Neck. PMID 32681692 DOI: 10.1002/Hed.26357 |
0.337 |
|
| 2020 |
Gamez ME, Blakaj A, Zoller W, Bonomi M, Blakaj DM. Emerging Concepts and Novel Strategies in Radiation Therapy for Laryngeal Cancer Management. Cancers. 12. PMID 32580375 DOI: 10.3390/Cancers12061651 |
0.426 |
|
| 2020 |
Wolfe AR, Blakaj D, London N, Blakaj A, Klamer B, Pan J, Wakely P, Prevedello L, Bonomi M, Bhatt A, Raval R, Palmer J, Prevedello D, Gamez M, Carrau R. Clinical Outcomes and Multidisciplinary Patterns of Failure for Olfactory Neuroblastoma: The Ohio State Experience. Journal of Neurological Surgery. Part B, Skull Base. 81: 287-294. PMID 32500004 DOI: 10.1055/S-0039-1692479 |
0.353 |
|
| 2020 |
Eckstein JM, Nolan N, Healy E, Wright CL, Jain A, Barney CL, Washington I, McElroy JP, Grecula JC, Wobb JL, Mitchell DL, Miller E, Gamez M, Blakaj D, Diavolitsis V, et al. Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy. Head & Neck. PMID 32391626 DOI: 10.1002/Hed.26242 |
0.337 |
|
| 2020 |
Palmer JD, Sebastian NT, Chu J, DiCostanzo D, Bell EH, Grecula J, Arnett A, Blakaj DM, McGregor J, Elder JB, Lu L, Zoller W, Addington M, Lonser R, Chakravarti A, et al. Single-Isocenter Multitarget Stereotactic Radiosurgery Is Safe and Effective in the Treatment of Multiple Brain Metastases. Advances in Radiation Oncology. 5: 70-76. PMID 32051892 DOI: 10.1016/J.Adro.2019.08.013 |
0.327 |
|
| 2020 |
Stauch Z, Zoller W, Tedrick K, Walston S, Christ D, Hunzeker A, Lenards N, Culp L, Gamez ME, Blakaj D. An evaluation of adaptive planning by assessing the dosimetric impact of weight loss throughout the course of radiotherapy in bilateral treatment of head and neck cancer patients Medical Dosimetry. 45: 52-59. PMID 31221447 DOI: 10.1016/J.Meddos.2019.05.003 |
0.349 |
|
| 2020 |
Subramaniam RM, Demora L, Yao M, Yom SS, Gillison ML, Caudell JJ, Waldron J, Xia P, Chung CH, Truong M, Harrison LB, Chan J, Geiger JL, Mell L, Seaward SA, ... ... Blakaj D, et al. 18 FDG PET/CT prediction of treatment outcomes in patients with p16-positive, non-smoking associated, locoregionally advanced oropharyngeal cancer (LA-OPC) receiving deintensified therapy: Results from NRG-HN002. Journal of Clinical Oncology. 38: 6563-6563. DOI: 10.1200/Jco.2020.38.15_Suppl.6563 |
0.314 |
|
| 2020 |
Bonomi MR, Sher D, Blakaj D, Kabarriti R, Colvett K, Oronsky B, Sonis ST, Bianco JA. Results of a randomized, open-label, multicenter trial to assess the safety, dose, and schedule ofRRx-001(001) in reducing incidence, severity and duration of severe oral mucositis (SOM) inpatients receiving concomitant chemoradiation (CRT) for advanced head and neck cancer (HNC). Journal of Clinical Oncology. 38: 12081-12081. DOI: 10.1200/Jco.2020.38.15_Suppl.12081 |
0.352 |
|
| 2020 |
Ridge JA, Ringash J, Yao M, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Dignam JJ, Le QT, Gillison ML, et al. Abstract IA20: Radiotherapy plus cetuximab or cisplatin in human papilloma-virus positive oropharyngeal cancer (NRG 1016): A randomized multicenter noninferiority trial* Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Aacrahns19-Ia20 |
0.407 |
|
| 2020 |
London N, Mohyeldin A, Daoud G, Blakaj D, Gamez M, Carrau R. Sinonasal Undifferentiated Carcinoma: An Institutional Trend towards Induction Chemotherapy followed by Definitive Chemoradiation Skull Base Surgery. 81. DOI: 10.1055/S-0040-1702313 |
0.367 |
|
| 2020 |
Wong S, Torres-Saavedra P, Le QT, Chung C, Jang S, Huq MS, Jordan R, Clump DA, Blakaj DM, Straza MW, Koyfman S. Safety of reRT with SBRT plus concurrent and adjuvant pembrolizumab in patients with recurrent or new second primary head and neck squamous cell cancer in a previously irradiated field: RTOG 3507 Foundation (KEYSTROKE) International Journal of Radiation Oncology Biology Physics. 106: 1224-1225. DOI: 10.1016/J.Ijrobp.2020.02.010 |
0.41 |
|
| 2020 |
Anderson CM, Lee CM, Saunders D, Curtis AE, Dunlap NE, Nangia C, Lee A, Gordon SM, Kovoor P, Bar-Ad V, Peddada AV, Colvett KT, Blakaj DM, Bonomi M, Worden F, et al. Tumor Outcomes of Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer International Journal of Radiation Oncology Biology Physics. 106: 1221-1222. DOI: 10.1016/J.Ijrobp.2020.02.004 |
0.352 |
|
| 2020 |
Geraghty L, Hoffman S, Schultz T, Porter K, Issa M, Rupert R, Bhateja P, Old M, Rocco JW, Blakaj DM, Bonomi M. Weekly Versus Tri-Weekly Paclitaxel and Carboplatin in Combination with Cetuximab in Recurrent/Metastatic Head and Neck Cancer Patients: a Toxicity Analysis International Journal of Radiation Oncology Biology Physics. 106: 1199. DOI: 10.1016/J.Ijrobp.2019.11.049 |
0.415 |
|
| 2019 |
Anderson CM, Lee CM, Saunders DP, Curtis A, Dunlap N, Nangia C, Lee AS, Gordon SM, Kovoor P, Arevalo-Araujo R, Bar-Ad V, Peddada A, Colvett K, Miller D, Jain AK, ... ... Blakaj D, et al. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901507. PMID 31618127 DOI: 10.1200/Jco.19.01507 |
0.384 |
|
| 2019 |
Beckham TH, Barney C, Healy E, Wolfe AR, Branstetter A, Yaney A, Riaz N, McBride SM, Tsai CJ, Kang J, Yu Y, Chen L, Sherman E, Dunn L, Pfister DG, ... ... Blakaj DM, et al. Platinum-Based Regimens Versus Cetuximab in Definitive Chemoradiation for Human Papillomavirus-Unrelated Head and Neck Cancer. International Journal of Cancer. PMID 31609479 DOI: 10.1002/Ijc.32736 |
0.367 |
|
| 2019 |
Blakaj A, Bonomi M, Gamez ME, Blakaj DM. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data. Oral Oncology. 95: 29-34. PMID 31345391 DOI: 10.1016/J.Oraloncology.2019.05.013 |
0.389 |
|
| 2019 |
Yang L, Kumar B, Shen C, Zhao S, Blakaj D, Li T, Romito M, Teknos TN, Williams TM. LCL161, a SMAC mimetic, Preferentially Radiosensitizes Human Papillomavirus Negative Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. PMID 31015310 DOI: 10.1158/1535-7163.Mct-18-1157 |
0.341 |
|
| 2019 |
Wald P, Grecula J, Walston S, Wei L, Bhatt A, Martin D, Bonomi M, Rocco J, Old M, Teknos T, Blakaj D. Intraoperative electron beam radiotherapy for locoregionally persistent or recurrent head and neck cancer. Head & Neck. PMID 30779458 DOI: 10.1002/Hed.25673 |
0.383 |
|
| 2019 |
Mladkova N, Blakaj D. TCGA data reveal a transcriptomic signature of Sox2 and Nanog targets associated with survival in head and neck cancer. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E17546 |
0.347 |
|
| 2019 |
Gillison ML, Ferris RL, Harris J, Colevas AD, Mell LK, Kong C, Jordan RC, Moore K, Truong MT, Kirsch C, Clump DA, Ohr J, He K, Blakaj D, Deeken JF, et al. Safety and disease control achieved with the addition of nivolumab (Nivo) to chemoradiotherapy (CRT) for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG Foundation 3504. Journal of Clinical Oncology. 37: 6073-6073. DOI: 10.1200/Jco.2019.37.15_Suppl.6073 |
0.35 |
|
| 2019 |
Bauman JE, Harris J, Uppaluri R, Yao M, Ferris RL, Chen J, Jordan RC, Joshi NP, Jujjuvaparu S, Blakaj D, Razaq M, Sheqwara J, Mell LK, Sen N, Clump DA, et al. NRG-HN003: Phase I and expansion cohort study of adjuvant cisplatin, intensity-modulated radiation therapy (IMRT), and MK-3475 (Pembrolizumab) in high-risk head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. 37: 6023-6023. DOI: 10.1200/Jco.2019.37.15_Suppl.6023 |
0.406 |
|
| 2019 |
Kim S, Khushalani NI, Eroglu Z, Russell J, Wuthrick E, Caudell J, Harrison L, Aoki M, Shah H, Blakaj D, Markowitz J, Chen D-, Messina J, Rose T, Tsai K, et al. A phase II, randomized study of nivolumab (NIVO) and Ipilimumab (IPI) versus NIVO, IPI and stereotactic body radiation therapy (SBRT) for metastatic Merkel cell carcinoma (MCC, NCT03071406): A preliminary report Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz255.010 |
0.309 |
|
| 2019 |
Issa M, Mousa L, Blakaj D, Klamer B, Pan J, Old M, Kang S, Rupert R, Mitchell D, Ozer E, Agrawal A, Bhateja P, Gamez M, Miller E, Jhawar S, et al. Treatment outcomes of head and neck cancer patients 70 years and older receiving different chemo-radiation combinations Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz252.018 |
0.38 |
|
| 2019 |
Fabian D, Wuthrick E, Wei L, Tan J, Grecula J, Welliver M, Williams T, Elder J, Raval R, Blakaj D, Haglund K, Bazan J, Kendra K, Liebner D, Puduvalli V, et al. Phase I Study of Trametinib in Combination with Whole-Brain Radiation Therapy for Brain Metastases International Journal of Radiation Oncology*Biology*Physics. 105: E74. DOI: 10.1016/J.Ijrobp.2019.06.2331 |
0.3 |
|
| 2019 |
Mladkova N, Blakaj DM. TCGA Data Reveal a Transcriptomic Signature of Sox2 and Nanog Targets Associated with Survival in Head and Neck Cancer International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1636 |
0.345 |
|
| 2019 |
Mladkova N, Mitchell DL, Gamez ME, Grecula JC, Jhawar SR, Miller ED, Old M, Blakaj DM. Gene Expression Analysis of Oral Tongue Carcinoma TCGA Data Reveals an Eighteen-Gene Signature Associated with Survival Following Radiation Treatment International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1596 |
0.337 |
|
| 2018 |
Teknos TN, Grecula J, Agrawal A, Old MO, Ozer E, Carrau R, Kang S, Rocco J, Blakaj D, Diavolitsis V, Kumar B, Kumar P, Pan Q, Palettas M, Wei L, et al. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma. Investigational New Drugs. PMID 30569244 DOI: 10.1007/S10637-018-0696-4 |
0.427 |
|
| 2018 |
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet (London, England). PMID 30449625 DOI: 10.1016/S0140-6736(18)32779-X |
0.399 |
|
| 2018 |
Bonomi MR, Blakaj A, Blakaj D. Organ preservation for advanced larynx cancer: A review of chemotherapy and radiation combination strategies. Oral Oncology. 86: 301-306. PMID 30409316 DOI: 10.1016/J.Oraloncology.2018.10.004 |
0.42 |
|
| 2018 |
Barney CL, Walston S, Zamora P, Healy EH, Nolan N, Diavolitsis VM, Neki A, Rupert R, Savvides P, Agrawal A, Old M, Ozer E, Carrau R, Kang S, Rocco J, ... ... Blakaj D, et al. Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma. Oral Oncology. 79: 9-14. PMID 29598954 DOI: 10.1016/J.Oraloncology.2018.02.001 |
0.36 |
|
| 2018 |
Philips R, Martin D, Eskander A, Schord J, Brown N, Zhao S, Brock G, Kumar B, Carrau R, Ozer E, Agrawal A, Kang SY, Rocco JW, Schuller D, Ali S, ... Blakaj D, et al. Effect of adjuvant radiotherapy treatment center volume on overall survival. Oral Oncology. 78: 46-51. PMID 29496057 DOI: 10.1016/J.Oraloncology.2018.01.004 |
0.43 |
|
| 2018 |
Das J, Custer A, Blakaj D, Old MO, Zhao S, Bhatt AD, Kang SY, Agrawal A, Ozer E, Wobb J, Rupert R, Mitchell DL, Brock G, Verschraegen CF, Rocco JW, et al. Incidence of ototoxicity in head and neck cancer (HNSCC) patients (pts) receiving concomitant chemo-radiation (CRT) with weekly or triweekly cisplatin (Cis). Journal of Clinical Oncology. 36: 6046-6046. DOI: 10.1200/Jco.2018.36.15_Suppl.6046 |
0.369 |
|
| 2018 |
Ferris RL, Gillison ML, Harris J, Colevas AD, Mell LK, Kong C, Jordan R, Moore K, Truong MT, Kirsch C, Clump DA, Ohr J, He K, Blakaj D, Deeken JF, et al. Safety evaluation of nivolumab (Nivo) concomitant with cetuximab-radiotherapy for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG 3504. Journal of Clinical Oncology. 36: 6010-6010. DOI: 10.1200/Jco.2018.36.15_Suppl.6010 |
0.376 |
|
| 2018 |
Trotti A, Harris J, Gillison M, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Galvin JM, Koyfman S, Blakaj D, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, et al. NRG-RTOG 1016: Phase III Trial Comparing Radiation/Cetuximab to Radiation/Cisplatin in HPV-related Cancer of the Oropharynx International Journal of Radiation Oncology Biology Physics. 102: 1604-1605. DOI: 10.1016/J.Ijrobp.2018.08.051 |
0.374 |
|
| 2018 |
Blakaj DM, Custer A, Zoller W, Wolfe AR, Bhatt AD, Grams S, Old M, Kang S, Agrawal A, Ozer E, Wobb JL, Rupert R, Mitchell DL, Verschraegen C, Rocco JW, et al. A Prospective Analysis of Ototoxicity in Modern Radiation Therapy Treatments for Head and Neck Squamous Cell Carcinoma (HNSCC) Patients Receiving Concomitant Chemo-Radiation (CRT) with Weekly or Tri-weekly Cisplatin (Cis) International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.786 |
0.45 |
|
| 2018 |
Wolfe AR, Klamer B, Pan J, Prevedello D, Bhatt AD, Palmer JD, Prevedello L, Wakely P, Bonomi M, Carrau R, Blakaj DM. The Impact of Adjuvant Radiation Therapy and Elective Nodal Irradiation in Early Stage/Low Grade versus Advanced Stage/High Grade Olfactory Neuroblastoma International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1085 |
0.334 |
|
| 2018 |
Barney C, Beckham T, Healy E, Branstetter A, Yaney A, Riaz N, McBride SM, Tsai CJ, Sherman E, Dunn L, Pfister DG, Tan J, Rupert R, Bonomi M, Mitchell DL, ... ... Blakaj DM, et al. A Multi-Institutional Comparison of Carboplatin-Based Regimens Versus Cetuximab in Chemoradiation for p16(-) Head and Neck Cancer International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.100 |
0.369 |
|
| 2018 |
Willen B, Healy E, Barney C, Walston S, DiCostanzo D, Ayan A, Wobb J, Mitchell D, Grecula J, Blakaj D, Bhatt A. Correlation of Salivary Gland Dose to Volume Changes Noted During Adaptive Replanning of Head and Neck Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 100: 1398-1399. DOI: 10.1016/J.Ijrobp.2017.12.234 |
0.38 |
|
| 2018 |
Healy E, Christ D, Cetnar A, DiCostanzo DJ, Wobb JL, Mitchell DL, Grecula JC, Bhatt AD, Blakaj DM. Dosimetric and Volumetric Effects of Induction Chemotherapy in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Oropharynx International Journal of Radiation Oncology Biology Physics. 100: 1341. DOI: 10.1016/J.Ijrobp.2017.12.091 |
0.385 |
|
| 2018 |
Barney C, Branstetter A, Yaney A, Healy E, Rupert R, Neki A, Walston SA, Diavolitsis VM, Blakaj DM, Wobb JL, Mitchell DL, Grecula JC, Savvides P, Bhatt AD. Carboplatin-Based Chemoradiation Improves Outcomes Compared to Cetuximab Bioradiation in Cisplatin Ineligible Locally Advanced p16 Negative Head and Neck cancer International Journal of Radiation Oncology Biology Physics. 100: 1327-1328. DOI: 10.1016/J.Ijrobp.2017.12.058 |
0.379 |
|
| 2018 |
Gillison M, Ferris R, Zhang Q, Colevas A, Mell L, Kirsch C, Moore K, Truong M, Kong C, Jordan R, Clump D, Ohr J, He K, Blakaj D, Deeken J, et al. Safety Evaluation of Nivolumab Concomitant With Platinum-Based Chemoradiation therapy for Intermediate and High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504 International Journal of Radiation Oncology*Biology*Physics. 100: 1307-1308. DOI: 10.1016/J.Ijrobp.2017.12.022 |
0.387 |
|
| 2017 |
Miller ED, Blakaj DM, Swanson BJ, Xiao W, Gillison ML, Wei L, Bhatt AD, Diavolitsis VM, Wobb JL, Kang SY, Carrau RL, Grecula JC. Sinonasal adenoid cystic carcinoma: Treatment outcomes and association with human papillomavirus. Head & Neck. PMID 28370900 DOI: 10.1002/Hed.24778 |
0.329 |
|
| 2017 |
Fabian D, McElroy J, Bhatt AD, Blakaj DM, Mitchell DL, Grecula JC, Wobb JL, Diavolitsis VM. Poster ViewingSurvey to Assess the Practice Patterns of Induction Chemotherapy (IC) in Head and Neck Cancer Patients International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1546 |
0.335 |
|
| 2017 |
Barney C, Healy E, Zamora P, Aljabban J, Walston SA, Diavolitsis VM, Blakaj DM, Wobb JL, Mitchell DL, Grecula JC, Neki A, Rupert R, Savvides P, Bhatt AD. Carboplatin Versus Cetuximab Chemoradiation in Cisplatin Ineligible Patients with Locally Advanced p16 Negative Head and Neck Squamous Cell Carcinoma International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1372 |
0.402 |
|
| 2016 |
Allan E, Hamedani H, Van Putten M, Blakaj DM. Novel Dosimetric Comparison of Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy Delivery When Using Dental Stents for Protection of Oral Mucosa. International Journal of Radiation Oncology, Biology, Physics. 96: E654. PMID 27675274 DOI: 10.1016/J.Ijrobp.2016.06.2267 |
0.336 |
|
| 2016 |
Allan E, Barney C, Baum S, Diavolitsis VM, Blakaj DM, Wobb JL, Kessling T, Van Putten M, Bhatt AD. Laser Debridement Combined With Low-Level Laser Biostimulation Improves Healing and Pain Control for Oral Mucositis When Compared to Standard Supportive Care in Patients Receiving Concurrent Cetuximab and Radiation for Oropharyngeal Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E529-E530. PMID 27674934 DOI: 10.1016/J.Ijrobp.2016.06.1954 |
0.303 |
|
| 2016 |
Teknos TN, Old MO, Grecula JC, Agrawal A, Ozer E, Carrau R, Kang S, Rocco JW, Blakaj D, Diavolitsis V, Baiocchi RA, Kumar B, Savvides P. A phase 1 trial of vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced stage head and neck squamous cell carcinoma. Journal of Clinical Oncology. 34: 6036-6036. DOI: 10.1200/Jco.2016.34.15_Suppl.6036 |
0.411 |
|
| 2016 |
Miller ED, Blakaj D, Walston SA, Bhatt AD, Diavolitsis VM, Grecula JC. Treatment Outcomes of Advanced Sinonasal Adenoid Cystic Carcinoma International Journal of Radiation Oncology Biology Physics. 94: 956. DOI: 10.1016/J.Ijrobp.2015.12.310 |
0.331 |
|
| 2016 |
Wald P, Blakaj D, Swanson B, Schuller D, Hamedani H, Agrawal A, Ozer E, Teknos T, Old M, Rocco J, Bhatt A, Diavolitsis V, Wei L, Grecula J. Human Papillomavirus Status and Long-Term Outcomes for Stage III-IV Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Hypopharynx Treated With a Multimodal Intensification Regimen International Journal of Radiation Oncology*Biology*Physics. 94: 896-897. DOI: 10.1016/J.Ijrobp.2015.12.100 |
0.354 |
|
| 2016 |
Martin D, Kumar B, Brown N, Agrawal A, Ozer E, Kang S, Rocco JW, Carrau R, Schuller D, Grecula JC, Bhatt AD, Blakaj D, Teknos T, Diavolitsis VM, Old M. Survival Is Independent of Radiation Therapy Treatment Center Experience After Surgical Therapy International Journal of Radiation Oncology Biology Physics. 94: 888. DOI: 10.1016/J.Ijrobp.2015.12.078 |
0.357 |
|
| 2016 |
Allan E, Barney C, Baum S, Kessling T, Diavolitsis VM, Blakaj D, Grecula JC, Rocco JW, Putten MV, Bhatt AD. Low-Level Laser Therapy and Laser Debridement for Management of Oral Mucositis in Patients With Head and Neck Cancer Receiving Chemotherapy and Radiation International Journal of Radiation Oncology Biology Physics. 94: 883. DOI: 10.1016/J.Ijrobp.2015.12.066 |
0.373 |
|
| 2016 |
Allan E, Lu L, Hooman H, Chakravarti A, Putten MV, Blakaj D. Dosimetric Verification of Dental Stent Efficacy in Head and Neck Radiation Therapy Using Modern Radiation Therapy Techniques: Quality of Life (QOL) and Treatment Compliance Implications International Journal of Radiation Oncology Biology Physics. 94: 875-876. DOI: 10.1016/J.Ijrobp.2015.12.046 |
0.363 |
|
| 2016 |
Allan E, Lu L, Hamedani H, Diavolitsis V, Bhatt A, Grecula J, Wobb J, Kessling T, Putten MV, Blakaj D. Dosimetric verification of dental stent efficacy in head and neck radiation therapy using modern radiation therapy techniques: quality of life and treatment compliance implications Journal of Radiation Oncology. 5: 351-358. DOI: 10.1007/S13566-016-0268-1 |
0.365 |
|
| 2015 |
Nolan N, Grecula JC, Blakaj D, Diavolitsis VM, Bhatt AD. Impact of anemia in oropharyngeal cancer patients treated with concurrent chemoradiation. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E17087 |
0.405 |
|
| 2015 |
Lu L, Allan E, Putten MV, Gupta N, Blakaj D. SU-F-BRB-15: Dosimetric Study of Radiation Therapy for Head/Neck Patients with Metallic Dental Fixtures Medical Physics. 42: 3533-3533. DOI: 10.1118/1.4925210 |
0.351 |
|
| 2015 |
Allan E, Lu L, Chakravarti A, Putten MV, Blakaj D. Mitigation of Secondary Electrons Caused by Dental Alloys in Head and Neck Radiation Therapy Using Dental Stents International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1800 |
0.347 |
|
| 2015 |
Nolan N, Diavolitsis VM, Blakaj D, Pan X, Grecula JC, Savvides P, Bhatt AD. Intensity Modulated Radiation Therapy With Cetuximab Versus Platinum Chemotherapy in p16-Positive Oropharyngeal Squamous Cell Carcinoma International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1397 |
0.412 |
|
| 2014 |
Walston SA, Blakaj D, Kumar B, Choudhary M, Palanichamy K, Nolan N, Miller E, Mourad WF, Kumar P, Bhatt A, Diavolitsis V, Grecula JC, Old M, Teknos T, Chakravarti A. Papillomavirus E2 Protein as a Biomarker for Radiation Sensitivity in HPV Associated Head and Neck Squamous Cell Carcinoma International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.2348 |
0.386 |
|
| 2013 |
Blakaj DM, Zhang HG, Blakaj A, Mourad WF, Clarke B, Spierer M, Kalnicki S, Guha C. Clinical and molecular exploration of the impact of radiation therapy on Marfan syndrome patients. Practical Radiation Oncology. 3: e127-30. PMID 24674374 DOI: 10.1016/J.Prro.2012.07.006 |
0.313 |
|
| 2013 |
Mourad WF, Shasha D, Blakaj DM, Khorsandi AS, Shourbaji RA, Glanzman J, Kabarriti R, Young R, Patel S, Katsoulakis E, Gámez M, Woode R, Lazarus C, Concert C, Hu KS, et al. Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes. Anticancer Research. 33: 4483-9. PMID 24123019 |
0.31 |
|
| 2013 |
Mourad WF, Hu KS, Shourbaji RA, Dolan J, Blakaj DM, Shasha D, Harrison LB. Exploration of the role of radiotherapy in the management of early glottic cancer with complete carotid artery occlusion. Onkologie. 36: 433-5. PMID 23921763 DOI: 10.1159/000353750 |
0.346 |
|
| 2013 |
Mourad WF, Blakaj DM, Kabarriti R, Young R, Shourbaji RA, Glanzman J, Patel S, Yaparpalvi R, Kalnicki S, Garg MK. Lack of adjuvant radiotherapy may increase risk of retropharyngeal node recurrence in patients with squamous cell carcinoma of the head and neck after transoral robotic surgery. Case Reports in Oncological Medicine. 2013: 727904. PMID 23840995 DOI: 10.1155/2013/727904 |
0.398 |
|
| 2013 |
Mourad WF, Young BM, Young R, Blakaj DM, Orhi N, Shourbaji RA, Manolidis S, Gámez M, Kumar M, Khorsandi A, Khan MA, Shasha D, Blakaj A, Glanzman J, Garg MK, et al. Clinical validation and applications for CT-based atlas for contouring the lower cranial nerves for head and neck cancer radiation therapy. Oral Oncology. 49: 956-63. PMID 23623404 DOI: 10.1016/J.Oraloncology.2013.03.449 |
0.349 |
|
| 2013 |
Shcherba M, Viswanathan S, Blakaj D, Garg M, Haigentz M. Treatment-associated mortality in head and neck cancer: Analysis of phase III trials. Journal of Clinical Oncology. 31: 6064-6064. DOI: 10.1200/Jco.2013.31.15_Suppl.6064 |
0.41 |
|
| 2013 |
Mourad WF, Blakaj DM, Young R, Ohri N, Gámez M, Shourbaji RA, Glanzman J, Hu KS, Garg MK, Harrison LB. Lower Cranial Nerves Contouring Atlas for Head-and-Neck Cancer Radiation Therapy International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1235 |
0.382 |
|
| 2012 |
Blakaj D, Godoy-Scripes P, Skinner WK, Viswanathan S, Haynes H, Eng Y, Sarta C, Haigentz M, Schiff BA, Smith RV, Guha C, Kalnicki S, Garg M. Prospective analysis of qol in patients undergoing concurrent chemotherapy and radiation therapy for locally advanced head and neck cancer. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E16058 |
0.444 |
|
| 2012 |
Blakaj D, Kinon M, Hong L, Kalnicki S, Lasala P, Grarg M. Radiation Necrosis After Radiosurgery: Correlation of Volume and Dose Parameters in Patients With Metastatic Brain Lesions International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.2202 |
0.306 |
|
| 2012 |
Blakaj D, Garg M, Chen Z, Smith R, Prystowsky M, Burk R, Schlecht N, Guha C, Kalnicki S. Characterization of Human Papillomavirus 16 Variants in Head-and-Neck Squamous Cell Carcinoma Patients International Journal of Radiation Oncology*Biology*Physics. 84: S711-S712. DOI: 10.1016/J.Ijrobp.2012.07.1904 |
0.375 |
|
| 2011 |
Blakaj D, Fox JL, Manzerova J, Hannan R, Hong L, Mehta KJ, Kalnicki S. Toxicity of hypofractionated adjuvant radiation after breast-conserving surgery for DCIS. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 128. PMID 27958174 DOI: 10.1200/Jco.2011.29.27_Suppl.128 |
0.317 |
|
| 2011 |
Hannan R, Shan J, Gandhi S, Bernstein K, Blakaj D, Montagna C, Tong T, Kalnicki S, Garg M, Guha C. TMPRSS2-ERG Loci Abnormality in Salvage Radiation Therapy (sRT) Refractory Prostate Cancer Patients International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1169 |
0.349 |
|
| 2009 |
Blakaj DM, Fernandez-Fuentes N, Chen Z, Hegde R, Fiser A, Burk RD, Brenowitz M. Evolutionary and biophysical relationships among the papillomavirus E2 proteins. Frontiers in Bioscience (Landmark Edition). 14: 900-17. PMID 19273107 DOI: 10.2741/3285 |
0.54 |
|
| 2006 |
Blakaj DM, Kattamuri C, Khrapunov S, Hegde RS, Brenowitz M. Indirect readout of DNA sequence by papillomavirus E2 proteins depends upon net cation uptake. Journal of Molecular Biology. 358: 224-40. PMID 16513133 DOI: 10.1016/J.Jmb.2006.01.093 |
0.525 |
|
| Show low-probability matches. |